JVMCX | TCMVX | JVMCX / TCMVX | |
Total Expense Ratio | 1.85 | 0.81 | 228% |
Annual Report Gross Expense Ratio | 1.86 | 0.81 | 230% |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 11.818 | 7.339 | 161% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.2B | 1.61B | 1,505% |
Annual Yield % from dividends | 0.00 | 1.34 | - |
Returns for 1 year | 1.84 | 5.01 | 37% |
Returns for 3 years | 19.79 | 11.56 | 171% |
Returns for 5 years | 51.15 | 38.40 | 133% |
Returns for 10 years | 45.25 | -13.72 | -330% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VTN | 10.73 | 0.14 | +1.32% |
Invesco Trust for Investment Grade New York Municipals | |||
BBSB | 99.29 | -0.04 | -0.04% |
JPMorgan BetaBuilders U.S. TrsBd1-3YrETF | |||
PBUS | 66.11 | -0.03 | -0.05% |
Invesco MSCI USA ETF | |||
IGE | 48.12 | -0.30 | -0.62% |
iShares North American Natural Res ETF | |||
GSKH | 57.13 | -0.87 | -1.50% |
GSK PLC ADRHEDGED GSKH |